Titlebook: New Anticancer Drugs; Fourth Annual Progra Stephen K. Carter,Yoshia Sakurai Book 1980 Springer-Verlag Berlin Heidelberg 1980 Drugs.Zytostat

raff淫雨霏霏

书目名称New Anticancer Drugs影响因子(影响力)




书目名称New Anticancer Drugs影响因子(影响力)学科排名




书目名称New Anticancer Drugs网络公开度




书目名称New Anticancer Drugs网络公开度学科排名




书目名称New Anticancer Drugs被引频次




书目名称New Anticancer Drugs被引频次学科排名




书目名称New Anticancer Drugs年度引用




书目名称New Anticancer Drugs年度引用学科排名




书目名称New Anticancer Drugs读者反馈




书目名称New Anticancer Drugs读者反馈学科排名

ENACT

MOAT

口诀法

Spina-Bifida

Phase II Study of Antineoplastic Agents in Japan,ffects, a satisfactory route of administration, and dose schedule are determined. Phase II is the screening in a broad spectrum of tumor types for evidence of a minimal degree of antitumor activity. Phase III is a trial to determine the degree of antitumor activity in one (or more) specific tumor ty

生命层

袖章

FIR

Continuation of Phase II Study of 1-(4-Amino-2-Methylpyrimidine-5-yl)-Methyl-3-(2-Chloroethyl)-3-Niitumor activity against various animal tumors, including L1210 mouse leukemia. The structural formulas for ACNU and the similar derivatives BCNU, CCNU, and methyl-CCNU are shown in Figure 1.I presented a paper on phase I and preliminary phase II studies of ACNU at the United States—Japan Cooperative

保存

Review of Experimental Studies on Nitrosourea Derivatives in Japan,otocin, are water-soluble compounds, and CDL-7 and EBNU are rather insoluble in water. The latter two are before clinical trials, and like other nitrosourea derivatives, have a marked antitumor activity in mouse leukemia L1210. Though GANU and MCNU are in the stage of clinical studies, it seems prem

Oscillate

The Clinical Evaluation of Analogues, IV. Nitrosoureas, the wide range of chemical structures that have been uncovered which have clinically demonstrated effective tumor cell kill. Since the ‘magic bullet’ has not yet been found, all effective anticancer drugs are limited by toxicity to normal tissues and inability to eradicate all tumor cells with the